- Home
- PLRX vs ORMP Comparison
PLRX vs ORMP Comparison
Compare PLRX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- ORMP
- Stock Information
- Founded
- PLRX 2015
- ORMP 2002
- Country
- PLRX United States
- ORMP United States
- Employees
- PLRX N/A
- ORMP N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- PLRX Health Care
- ORMP Health Care
- Exchange
- PLRX Nasdaq
- ORMP Nasdaq
- Market Cap
- PLRX 89.0M
- ORMP 90.2M
- IPO Year
- PLRX 2020
- ORMP N/A
- Fundamental
- Price
- PLRX $1.53
- ORMP $2.32
- Analyst Decision
- PLRX Hold
- ORMP Hold
- Analyst Count
- PLRX 10
- ORMP 1
- Target Price
- PLRX $3.93
- ORMP N/A
- AVG Volume (30 Days)
- PLRX 725.5K
- ORMP 96.9K
- Earning Date
- PLRX 11-06-2025
- ORMP 11-06-2025
- Dividend Yield
- PLRX N/A
- ORMP N/A
- EPS Growth
- PLRX N/A
- ORMP N/A
- EPS
- PLRX N/A
- ORMP N/A
- Revenue
- PLRX N/A
- ORMP $2,000,000.00
- Revenue This Year
- PLRX N/A
- ORMP N/A
- Revenue Next Year
- PLRX N/A
- ORMP N/A
- P/E Ratio
- PLRX N/A
- ORMP N/A
- Revenue Growth
- PLRX N/A
- ORMP N/A
- 52 Week Low
- PLRX $1.10
- ORMP $1.82
- 52 Week High
- PLRX $16.10
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- PLRX 44.68
- ORMP 59.64
- Support Level
- PLRX $1.66
- ORMP $2.17
- Resistance Level
- PLRX $1.85
- ORMP $2.45
- Average True Range (ATR)
- PLRX 0.13
- ORMP 0.07
- MACD
- PLRX -0.02
- ORMP 0.02
- Stochastic Oscillator
- PLRX 12.20
- ORMP 61.76
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.